CalciMedica (CALC) Amortizatization of Intangibles (2019 - 2026)
CalciMedica's (CALC) quarterly Amortizatization of Intangibles came in at $4000.0 in Q1 2026, down 96.23% YoY from $106000.0 in Q1 2025, and down 89.47% on a QoQ basis from $38000.0 in Q4 2025.
CalciMedica (CALC) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 8 years of Amortizatization of Intangibles data on file, last reported at $4000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 96.23% year-over-year to $4000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $243000.0 (down 55.9% YoY) and the FY2025 annual result came in at $345000.0, down 43.26% from the prior year.
- Amortizatization of Intangibles fell to $4000.0 in Q1 2026, from $38000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $218000.0 in Q2 2024 to a low of $2000.0 in Q1 2023.
- A 5-year average of $83588.2 and a median of $89000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2024 — Amortizatization of Intangibles soared 8050.0% — and 2026, when it plunged 96.23%.
- Tracing CALC's Amortizatization of Intangibles over 5 years: stood at $191000.0 in 2022, then plunged by 56.02% to $84000.0 in 2023, then soared by 38.1% to $116000.0 in 2024, then slumped by 67.24% to $38000.0 in 2025, then tumbled by 89.47% to $4000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $4000.0 (Q1 2026), $38000.0 (Q4 2025), and $89000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CalciMedica | 9.80 Mn | -8.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,000.00 |
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | 38,000.00 |
| Dec 31, 2025 | 38,000.00 |
| Sep 30, 2025 | 89,000.00 |
| Sep 30, 2025 | 89,000.00 |
| Jun 30, 2025 | 112,000.00 |
| Jun 30, 2025 | 112,000.00 |
| Mar 31, 2025 | 106,000.00 |
| Mar 31, 2025 | 106,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Sep 30, 2024 | 111,000.00 |
| Sep 30, 2024 | 111,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Mar 31, 2024 | 163,000.00 |
| Mar 31, 2024 | 163,000.00 |
| Dec 31, 2023 | 84,000.00 |
| Dec 31, 2023 | 84,000.00 |